Diseases, Conditions, Syndromes

MRSA strain linked to high death rates

A strain of MRSA that causes bloodstream infections is five times more lethal than other strains and has shown to have some resistance to the potent antibiotic drug vancomycin used to treat MRSA, according to a Henry Ford ...

Diseases, Conditions, Syndromes

Vancomycin is the drug of choice for treating cellulitis

Patients admitted to the hospital for the common bacterial skin infection cellulitis should be treated as a first line of defense with the potent antibiotic drug vancomycin rather than other antibiotics such as penicillin, ...

Diseases, Conditions, Syndromes

Hydrogen peroxide vapor enhances hospital disinfection of superbugs

Infection control experts at The Johns Hopkins Hospital have found that a combination of robot-like devices that disperse a bleaching agent into the air and then detoxify the disinfecting chemical are highly effective at ...

Medical research

Researcher discovers new 'anti-pathogenic' drugs to treat MRSA

Menachem Shoham, PhD, associate professor and researcher in the department of biochemistry at the Case Western Reserve University School of Medicine, has identified new anti-pathogenic drugs that, without killing the bacteria, ...

Diseases, Conditions, Syndromes

hVISA linked to high mortality: study

A MRSA infection with a reduced susceptibility to the potent antibiotic drug vancomycin is linked to high mortality, according to a Henry Ford Hospital study.

page 1 from 6

Vancomycin

Vancomycin (INN) (pronounced /ˌvæŋkɵˈmaɪsɪn/) is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. It has traditionally been reserved as a drug of "last resort", used only after treatment with other antibiotics had failed, although the emergence of vancomycin-resistant organisms means that it is increasingly being displaced from this role by linezolid and daptomycin.

This text uses material from Wikipedia, licensed under CC BY-SA